STOCK PURCHASE AGREEMENTStock Purchase Agreement • March 16th, 2006 • Inverness Medical Innovations Inc • In vitro & in vivo diagnostic substances • New York
THIS STOCK PURCHASE AGREEMENT (the “Agreement”), is made and entered into as of February 3, 2006, by and among Inverness Medical Innovations, Inc. a Delaware corporation (the “Company”), and the undersigned prospective investor (the “Investor”).
THIRD AMENDMENT TO THIRD AMENDED AND RESTATED CREDIT AGREEMENTCredit Agreement • March 16th, 2006 • Inverness Medical Innovations Inc • In vitro & in vivo diagnostic substances • New York
THIRD AMENDMENT TO THIRD AMENDED AND RESTATED CREDIT AGREEMENT, dated as of November 22, 2005 (this “Amendment”), to the Third Amended and Restated Credit Agreement, dated as of June 30, 2005 (as amended, supplemented or otherwise modified from time to time, the “Credit Agreement”), by and among General Electric Capital Corporation, as Agent (in such capacity, “Agent”), Inverness Medical Innovations, Inc. (“Innovations”), Wampole Laboratories, LLC and Inverness Medical (UK) Holdings Limited, as borrowers (“Borrowers”), the other Credit Parties signatory thereto, Merrill Lynch Capital, a division of Merrill Lynch Business Financial Services Inc., as documentation agent, co-syndication agent and lender, UBS Securities LLC, as co-syndication agent, and the lenders signatory thereto from time to time (collectively, the “Lenders”).
LEASE BETWEEN THERMO BIOSTAR, INC., A DELAWARE COPRORATION AND THE PARK AT CTC, LLC, A COLORADO LIMITED LIABILITY COMPANYLease Agreement • March 16th, 2006 • Inverness Medical Innovations Inc • In vitro & in vivo diagnostic substances • Colorado
THIS LEASE made this 25th day of June, 2001 (“Effective Date”), between Thermo BioStar, Inc., a Delaware corporation (“Tenant”), and The Park at CTC, LLC, a Colorado limited liability company (“Landlord”).
FIRST AMENDMENT TO LEASELease • March 16th, 2006 • Inverness Medical Innovations Inc • In vitro & in vivo diagnostic substances
This FIRST AMENDMEN TTO LEASE (this “Amendment”) is entered into this day of November, 2002, between Thermo Biostar, Inc., a Delaware corporation (“Tenant”) and The Park at CTC, LLC, a Colorado limited liability company (“Landlord”).
STOCK PURCHASE AGREEMENT BY AND BETWEEN INVERNESS MEDICAL INNOVATIONS, INC., THERMO ELECTRON CORPORATION AND THERMO BIOANALYSIS CORPORATION Dated: September 16, 2005Stock Purchase Agreement • March 16th, 2006 • Inverness Medical Innovations Inc • In vitro & in vivo diagnostic substances • Massachusetts
This STOCK PURCHASE AGREEMENT (this “Agreement”) is hereby entered into on September 16, 2005, by and among Inverness Medical Innovations, Inc., a Delaware corporation (“Buyer”), Thermo Electron Corporation, a Delaware Corporation (“Parent”) with respect to Articles IIIA, V, VII, VIII, X, XI, XII, XIII and XIV only, and Thermo BioAnalysis Corporation, a Delaware corporation and a subsidiary of Parent (“Seller” and together with Parent, the “Sellers”). Buyer and Sellers are individually referred to herein as a “Party” and collectively as the “Parties.”
FOURTH AMENDMENT AND CONSENT TO THIRD AMENDED AND RESTATED CREDIT AGREEMENTCredit Agreement • March 16th, 2006 • Inverness Medical Innovations Inc • In vitro & in vivo diagnostic substances • New York
FOURTH AMENDMENT AND CONSENT TO THIRD AMENDED AND RESTATED CREDIT AGREEMENT, dated as of February 27, 2006 (this “Amendment”), to the Third Amended and Restated Credit Agreement, dated as of June 30, 2005 (as amended, supplemented or otherwise modified from time to time, the “Credit Agreement”), by and among General Electric Capital Corporation, as Agent (in such capacity, “Agent”), Inverness Medical Innovations, Inc. (“Innovations”), Wampole Laboratories, LLC (“US Borrower”) and Inverness Medical (UK) Holdings Limited (“European Borrower”, together with US Borrower, collectively, “Borrowers”), the other Credit Parties signatory thereto, Merrill Lynch Capital, a division of Merrill Lynch Business Financial Services Inc., as documentation agent, co-syndication agent and lender, UBS Securities LLC, as co-syndication agent, and the lenders signatory thereto from time to time (collectively, the “Lenders”).
